Despite higher revision rate, MoM large-head THA offers better clinical scores than HR: 14-year results from a randomized controlled trial involving 48 patients.

2 , Table 2 ). When comparing PROMs of well-functioning implants (non-revised and without radiographic signs of implant dysfunction), LDH THA continues to demonstrate significantly better overall PJP results ( p = 0.04), while the rest of the scores differences did not reach statistical significance (WOMAC nearly significant with p = 0.05).

also in 3,287 other papers